Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: EN Brussels
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

MDXH:BB

4.9010 EUR 0.0740 1.49%

As of 11:35:00 ET on 05/29/2015.

Snapshot for MDxHealth (MDXH)

Open: 4.9800 Day's Range: 4.9010 - 4.9890 Volume: 92,322
Previous Close: 4.9750 52wk Range: 3.0720 - 5.8800 1-Yr Rtn: +17.16%

Stock Chart for MDXH

No chart data available.
  • MDXH:BB 4.9010
  • 1D
  • 1M
  • 1Y
4.9750
Interactive MDXH Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MDXH

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. BEL20 -
Earnings Per Share (EUR) (ttm) -0.3016
Est. EPS (EUR) (12/2015) -0.2700
Est. PEG Ratio -
Market Cap (M EUR) 184.65
Shares Outstanding (M) 37.68
30 Day Average Volume 150,881
Price/Book (mrq) 10.3195
Price/Sale (ttm) 21.2419
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/20/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MDXH

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for MDXH

MDxHealth is a molecular diagnostics company that develops and commercializes oncology based molecular diagnostic testing for personalized medicine. The Company's tests are based on proprietary gene methylation technology and assist physicians and their patients with the accurate diagnosis of cancer, prognosis of recurrence risk and prediction of response to a specific therapy.

Jan GroenPresident/CEOFrancis OtaChief Financial Officer
Christopher ThibodeauExec VP:Commercial OpsJoseph SolleeExec VP:Corporate Dev & Legal
More Company Profile & Key Executives for MDXH

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil